Kotak Healthcare Growth Direct Plan
SIP amount
Min. ₹100
Lumpsum amount
Min. ₹100

Kotak Healthcare Growth Direct Plan

NAV
₹14.0060
+0.19%
(8 Nov)
AUM
402 Cr
TER
0.74%
Risk
Very High Risk
Insights
Asset Under Management (AUM) is in the bottom 25% of comparable funds
Net Asset Value (NAV) is above its 200 days moving average
In beta. Send feedback here.
Compare with other fund
1Y
+67.7%
+67.5%
+61.0%
+55.3%
NA
3Y
+36.7%
+34.4%
+36.4%
+33.5%
NA
5Y
+26.1%
+29.6%
NA
+31.7%
NA
ALL
+13.0%
+18.4%
+31.0%
+18.5%
+39.8%
VOL
20.3%
19.6%
22.8%
18.2%
13.2%
TER
0.7%
0.8%
0.5%
1.2%
0.7%
AUM
₹4,703 Cr
₹1,436 Cr
₹5,896 Cr
₹6,424 Cr
₹402 Cr
INFO
0.64
0.94
1.36
1.02
3.00
Past performance
Past performance is no guarantee of future returns.
Had you invested
Over the last
1Y
3Y
ALL
Your returns would have been
Kotak Healthcare (G)
₹1,00,00,00,000
14.0%
Fixed deposit
₹40,00,00,000
6.0%
Bank savings
₹40,00,00,000
3.0%
See fund holdings as of 31st Aug
Top holdings
Sun Pharmaceuticals Industries Ltd
14.8%
Cipla Ltd
8.2%
Aurobindo Pharma Ltd
5.1%
Divi's Laboratories Ltd
4.9%
Torrent Pharmaceuticals Ltd
4.8%
Dr Reddy's Laboratories Ltd
4.7%
Max Healthcare Institute Ltd Ordinary Shares
4.1%
Marksans Pharma Ltd
4.1%
Alkem Laboratories Ltd
4.0%
Zydus Lifesciences Ltd
3.7%
Top industry exposure
Healthcare
97.4%
Basic Materials
1.7%
Other information
Minimum SIP
₹100
Minimum lumpsum
₹100
Additional lumpsum
₹100
Portfolio turnover
36%
Lock-in period
-
Exit load
• 1% for redemption within 30 days
Fund objective
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors. However, there is no assurance that the objective of the scheme will be achieved .
Fund manager(s)
Abhishek Bisen
Shibani Kurian
Dhananjay Tikariha

FAQs